Select Page

Functional RNAi and CRISPR Screening and Drug Target & Biomarker Discovery

Cellecta Inc., a functional genomics solutions provider, focuses primarily on developing and implementing flexible and scalable broad-based screening and analysis approaches for drug target and biomarker discovery. Our high-throughput functional genetic screening portfolio includes:

  • shRNA and CRISPR screening services
  • custom and off-the-shelf pooled libraries
  • knockout and knockdown cell lines

that facilitate genome-wide functional screening and the identification and validation of genes involved in critical biological and disease pathways.

With Driver-Map™ Targeted Gene Expression Profiling Service, Cellecta offers a quantitative, multiplexed approach that allows simultaneous profiling of all human protein-coding genes in one reaction, thereby providing a reliable, accurate transcriptome profile with ultra-high sensitivity.

 

Learn more about Cellecta >